Note 10 - Stockholders' Equity and Stock-based Compensation	3 Months Ended
Mar. 31, 2024
Notes to Financial Statements
Shareholders' Equity and Share-Based Payments [Text Block]	10. STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION Stock-based Compensation The Company includes stock compensation expense within general and administrative expenses in the Condensed Consolidated Statements of Operations. During the three months ended March 31, 2024 and 2023, the Company recognized $0.4 million and $0.6 million of stock compensation expense, respectively. Issuance of Stock-based Awards The Company has a long-term incentive plan (the “Amended and Restated Plan”) which provides for a maximum number of shares of common stock available for issuance of 5,500,000 shares. The plan was amended in 2023 to increase the maximum number of shares from 4,000,000 to 5,500,000, as approved by shareholders. Awards under the Amended and Restated Plan may be granted to employees, officers and directors of the Company and affiliates, and any other person who provides services to the Company and its affiliates (including independent contractors and consultants of the Company and its subsidiaries). Awards may be granted in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, dividend equivalents, substitute awards, other stock-based awards, cash awards and/or any combination of the foregoing. No participant may receive a grant covering more than 2,000,000 shares of our common stock in any year and a non-employee member of the Board may not be granted more than 100,000 shares in any year. The Company made no stock-based awards during the three months ended March 31, 2024. Issuances of Common Stock During the three months ended March 31, 2024, and 2023, shares of common stock were issued upon vesting of restricted stock units, net of withholding shares for tax payments, totaling 11,623 shares and 13,587 shares, respectively. There were no stock options or stock appreciation rights exercised during the three months ended March 31, 2024 or 2023.

Note 10 - Stockholders' Equity and Stock-based Compensation

3 Months Ended

Mar. 31, 2024

Shareholders' Equity and Share-Based Payments [Text Block]

10. STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION

Stock-based Compensation

The Company includes stock compensation expense within general and administrative expenses in the Condensed Consolidated Statements of Operations. During the three months ended March 31, 2024 and 2023, the Company recognized $0.4 million and $0.6 million of stock compensation expense, respectively.

Issuance of Stock-based Awards

The Company has a long-term incentive plan (the “Amended and Restated Plan”) which provides for a maximum number of shares of common stock available for issuance of 5,500,000 shares. The plan was amended in 2023 to increase the maximum number of shares from 4,000,000 to 5,500,000, as approved by shareholders. Awards under the Amended and Restated Plan may be granted to employees, officers and directors of the Company and affiliates, and any other person who provides services to the Company and its affiliates (including independent contractors and consultants of the Company and its subsidiaries). Awards may be granted in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, dividend equivalents, substitute awards, other stock-based awards, cash awards and/or any combination of the foregoing. No participant may receive a grant covering more than 2,000,000 shares of our common stock in any year and a non-employee member of the Board may not be granted more than 100,000 shares in any year.

The Company made no stock-based awards during the three months ended March 31, 2024.

Issuances of Common Stock

During the three months ended March 31, 2024, and 2023, shares of common stock were issued upon vesting of restricted stock units, net of withholding shares for tax payments, totaling 11,623 shares and 13,587 shares, respectively. There were no stock options or stock appreciation rights exercised during the three months ended March 31, 2024 or 2023.